| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.900 | None | 0.945 | 2 | 0 | 2004 | 2020 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.700 | None | 0.969 | 4 | 0 | 1982 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 5 | 0 | 1988 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.500 | None | 0.960 | 3 | 0 | 1989 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.948 | 2 | 0 | 1988 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.927 | 2 | 0 | 1998 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.950 | 3 | 0 | 1989 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.895 | 3 | 0 | 1993 | 2020 | ||||||||
|
hydroxysteroid 11-beta dehydrogenase 2 | 0.532 | 0.808 | 0.12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2006 | ||||||||
|
neuronal differentiation 1 | 0.543 | 0.808 | 0.77 |
|
disease | 0.300 | None | 0.727 | 2 | 0 | 1997 | 2006 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.300 | None | 0.818 | 1 | 0 | 2003 | 2019 | ||||||||
|
glutamate decarboxylase 2 | 0.529 | 0.731 | 0.75 |
|
disease | 0.300 | None | 0.938 | 1 | 0 | 1993 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type N | 0.736 | 0.346 | 8.0E-07 |
|
disease | 0.300 | None | 0.926 | 1 | 0 | 1994 | 2019 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.200 | None | 0.882 | 1 | 0 | 1990 | 2017 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.100 | None | 0.882 | 4 | 0 | 1996 | 2019 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.100 | None | 0.783 | 2 | 0 | 2001 | 2017 | ||||||||
|
small ubiquitin like modifier 4 | 0.653 | 0.577 |
|
disease | 0.100 | None | 0.879 | 1 | 0 | 1996 | 2017 | |||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 0.930 | 1 | 0 | 1997 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2001 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 0.962 | 1 | 0 | 2004 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1984 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 0.953 | 1 | 0 | 1990 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.100 | None | 0.786 | 1 | 0 | 1998 | 2019 |